East Africa Medical Oxygen Supply: Cost-Per-Litre Economics
- The Production Cost Is Not the Problem
- Cylinder Economics and the Hidden Cost of Metal Assets
- Route-Level Delivery Costs and the Distance Margin Decay
- Facility Consumption Patterns and Demand Forecasting
- The PSA Plant Investment Question and Scale Thresholds
- Investor Opportunity in Medical Gas Distribution Infrastructure
The conventional wisdom that medical oxygen is expensive in East Africa because production costs are high is wrong. Production at a modern PSA plant costs KES 0.80-1.50 per litre, but by the time a cylinder reaches a rural hospital bed, the delivered cost is KES 3.50-8.00 per litre, with distribution, cylinder logistics, and last-mile inefficiency accounting for 55-70% of the final price. Paul Mugambi runs a medical oxygen distribution business in Nairobi serving 34 healthcare facilities across central Kenya, and his operational data reveals that the oxygen access crisis is fundamentally a logistics problem, not a manufacturing one. AskBiz helps oxygen distributors like Paul optimise cylinder rotation schedules, route-level delivery costs, and facility-level consumption forecasting that compress the distribution margin and expand affordable access.
- The Production Cost Is Not the Problem
- Cylinder Economics and the Hidden Cost of Metal Assets
- Route-Level Delivery Costs and the Distance Margin Decay
- Facility Consumption Patterns and Demand Forecasting
- The PSA Plant Investment Question and Scale Thresholds
The Production Cost Is Not the Problem#
Every conversation about medical oxygen access in East Africa eventually centres on the need for more oxygen production capacity. More PSA plants, more cryogenic facilities, more concentrators. Paul Mugambi has spent four years in the medical oxygen distribution business, and he has concluded that this framing is fundamentally misleading. Kenya currently has sufficient installed oxygen production capacity to meet roughly 150-170% of current hospital demand in Nairobi and the central highlands. Three major industrial gas companies operate cryogenic air separation units in the Nairobi metropolitan area, producing medical-grade oxygen at 93-99.5% purity. Six smaller PSA oxygen plants, several installed during the COVID-19 pandemic with donor funding, add decentralised production capacity at county-level hospitals. The production cost at a well-run cryogenic plant is KES 0.50-0.80 per litre of gaseous oxygen equivalent. At a PSA plant, production costs are higher at KES 1.20-1.80 per litre due to smaller scale and higher per-unit electricity consumption, but still modest in absolute terms. The problem is not production. The problem is what happens between the plant gate and the patient's bedside. A medical oxygen cylinder holding 6,800 litres of gaseous oxygen at 150 bar pressure costs approximately KES 4,500-5,500 to fill at the plant gate. By the time Paul delivers that same cylinder to a sub-county hospital 120 kilometres from Nairobi, the customer price is KES 8,500-KES 12,000. The distribution chain, encompassing cylinder transport, vehicle depreciation, driver costs, cylinder deposit management, and return logistics for empty cylinders, has added 80-120% to the plant-gate cost. Paul's insight is that medical oxygen access in Kenya is not a chemistry problem. It is a logistics problem disguised as a healthcare crisis.
Cylinder Economics and the Hidden Cost of Metal Assets#
The economics of medical oxygen distribution are inseparable from the economics of the steel cylinders that contain it. Paul's fleet comprises 420 cylinders in various sizes: 47-litre Type D cylinders holding 6,800 litres of gas, 10-litre Type B cylinders holding 1,400 litres, and portable 2-litre cylinders for ambulance and home-care use. Each new 47-litre cylinder costs KES 28,000-KES 35,000 depending on supplier and current steel prices. The total replacement value of Paul's cylinder fleet exceeds KES 11 million. Cylinders are the single largest capital asset in his business, exceeding the value of his two delivery trucks. Cylinder management is operationally complex. Each cylinder has a 5-year hydrostatic testing cycle mandated by the Kenya Bureau of Standards. Testing costs KES 1,800-KES 2,500 per cylinder and takes the cylinder out of circulation for 5-10 days. Paul loses revenue on approximately 15-20 cylinders per month undergoing testing. Cylinder attrition is a persistent cost. Hospitals and clinics occasionally damage valves, lose protective caps, or fail to return cylinders within the agreed rotation period. Paul's average cylinder turnaround time, measured from delivery of a full cylinder to collection of the empty, is 8.5 days for Nairobi facilities and 14-18 days for upcountry hospitals. Longer turnaround times effectively reduce his usable fleet size. With 420 cylinders and an average turnaround of 12 days, Paul has approximately 280 cylinders productively deployed at any time, with 140 in transit, awaiting filling, undergoing testing, or sitting at facilities waiting for collection. AskBiz tracks every cylinder by serial number through its full lifecycle: fill date, delivery date, facility deployed, collection date, return condition, and testing schedule. This granular tracking has reduced Paul's average turnaround time from 15 days to 12 days over eight months, effectively increasing his productive fleet by 15% without purchasing additional cylinders.
Route-Level Delivery Costs and the Distance Margin Decay#
Paul operates two delivery routes from his depot in Nairobi's industrial area. Route A covers Nairobi facilities including hospitals, clinics, and dental surgeries within the metropolitan area, running daily. Route B covers upcountry facilities in Thika, Murang'a, Nyeri, and Nanyuki, running three times per week. Route A delivers 18-24 cylinders per day across 12-15 facilities. The delivery truck covers 60-100 kilometres daily in Nairobi traffic, with a direct delivery cost of KES 850-KES 1,200 per cylinder including fuel, driver salary allocation, and vehicle depreciation. At an average selling price of KES 8,500 per 47-litre cylinder, the delivery cost represents 10-14% of revenue. Route B delivers 15-20 cylinders per trip across 8-12 facilities over 300-450 kilometres. The direct delivery cost per cylinder on this route is KES 1,800-KES 2,600, representing 15-22% of the selling price of KES 10,000-KES 12,000 per cylinder for upcountry facilities. The price differential between Nairobi and upcountry deliveries partly reflects the higher delivery cost but does not fully recover it. Paul's gross margin per cylinder on Route A averages KES 3,200-KES 3,800, yielding a 38-45% gross margin. On Route B, the gross margin drops to KES 2,400-KES 3,000 per cylinder, or 24-30%. The margin decay with distance is not linear. It accelerates beyond 150 kilometres from Nairobi as fuel costs increase, round-trip time extends, and empty cylinder return logistics become more complex. Facilities beyond Nyeri, at 160 kilometres, are marginally profitable. Facilities in Nanyuki, at 200 kilometres, are break-even at best. Paul has considered extending his route to Meru and Isiolo but his AskBiz margin analysis shows these deliveries would be loss-making at current pricing without either a price increase or a minimum order quantity that small hospitals cannot meet.
Data-backed guides on AI, eCommerce, and SME strategy — straight to your inbox.
Facility Consumption Patterns and Demand Forecasting#
Medical oxygen demand at the facility level is variable in ways that complicate distribution planning. A Level 4 sub-county hospital with a 50-bed ward and a small surgical theatre consumes 8-15 cylinders of 47-litre capacity per month. A private hospital with an ICU and active surgical programme consumes 25-45 cylinders monthly. A dental clinic with sedation capability uses 2-4 small cylinders per month. Demand spikes are driven by three factors. Seasonal respiratory illness, particularly during the cold months of June through August in the central highlands, increases hospital oxygen consumption by 30-50%. Surgical scheduling creates weekly patterns, with Monday and Wednesday typically being heavy surgical days that increase oxygen draw. Emergency admissions, inherently unpredictable, can cause individual facilities to exhaust their oxygen supply unexpectedly. Stockouts at the facility level have serious clinical consequences. A hospital that runs out of oxygen must either transfer oxygen-dependent patients to another facility, borrow cylinders from nearby facilities at emergency premium pricing, or in the worst case face patient deterioration. Paul has documented 23 emergency delivery requests in the past 12 months, situations where a facility called because their supply was critically low or exhausted. Each emergency delivery costs him KES 4,000-KES 8,000 above his normal route delivery cost due to the unscheduled truck dispatch. He passes KES 2,000-KES 3,000 of this cost to the facility as a surcharge but absorbs the remainder to maintain the customer relationship. AskBiz models each facility's consumption pattern using historical delivery data, generating automated reorder alerts when estimated remaining supply drops below a 3-day buffer. This forecasting capability has reduced emergency deliveries from an average of 3.2 per month to 1.4 per month, saving Paul approximately KES 45,000 monthly in unscheduled delivery costs while improving oxygen availability for patients.
The PSA Plant Investment Question and Scale Thresholds#
Paul currently purchases filled cylinders from two of the three major industrial gas companies in Nairobi. His fill cost per 47-litre cylinder is KES 4,800-KES 5,500 depending on supplier and volume tier. He has been evaluating the feasibility of investing in his own PSA oxygen generation plant to vertically integrate production and capture the manufacturing margin. A containerised PSA plant producing 20-40 Nm3/hour of medical-grade oxygen at 93% or higher purity costs USD 120,000-USD 250,000 installed, equivalent to KES 15.5-KES 32.5 million at current exchange rates. Operating costs include electricity at KES 18-KES 22 per kWh for a compressor consuming 30-50 kW, maintenance consumables including zeolite molecular sieve replacement every 3-5 years at USD 15,000-USD 25,000, and a trained technician at KES 45,000-KES 65,000 monthly salary. At Paul's current volume of approximately 250 cylinder fills per month, a PSA plant operating at 60% capacity would produce oxygen at a cost of KES 2,800-KES 3,200 per cylinder equivalent, saving KES 1,600-KES 2,700 per cylinder versus his current purchase cost. Monthly savings of KES 400,000-KES 675,000 would yield a payback period of 30-48 months on the plant investment. However, the investment case is sensitive to utilisation. If monthly fill volume drops below 180 cylinders, the per-cylinder production cost rises above the external purchase price because fixed costs dominate. Scaling beyond 350 fills per month is constrained by Paul's distribution capacity rather than production. The optimal strategy, Paul's AskBiz models suggest, is to reach 350 monthly fills through distribution expansion before committing capital to a PSA plant. At that volume, the payback period compresses to 18-24 months, and the vertical integration creates a meaningful cost advantage over competitors who remain dependent on third-party fill pricing.
Investor Opportunity in Medical Gas Distribution Infrastructure#
The medical oxygen market in East Africa is projected to grow at 12-18% annually through 2030, driven by expanding hospital bed capacity, increasing surgical volumes, and growing recognition of oxygen as an essential medicine following the COVID-19 pandemic. The World Health Organization added medical oxygen to its Model List of Essential Medicines in 2017, and the Kenya Essential Medicines List includes medical oxygen across all levels of healthcare facilities. Yet the investment landscape for medical oxygen distribution remains fragmented and opaque. Paul is one of approximately 15-20 independent medical oxygen distributors operating in the Nairobi region, alongside the three major industrial gas companies. The independents collectively serve 60-70% of smaller private facilities and sub-county hospitals that the majors find too small or too remote to serve efficiently. The consolidation opportunity is significant. An operator who could aggregate 3-5 independent distributors would achieve sufficient scale to justify PSA plant investment, optimise route density across a combined facility network, and negotiate better fill pricing with the industrial gas majors during the transition period. Paul estimates that a consolidated distributor serving 100 or more facilities with 1,000 or more cylinders could achieve net margins of 18-22% versus his current 8-12%, driven by route density optimisation, production vertical integration, and reduced per-unit cylinder management costs. The barrier to consolidation is data. Potential acquisition targets operate with minimal financial records and no standardised operational metrics. AskBiz provides the data infrastructure that makes consolidation feasible. A distributor operating on AskBiz can present auditable cylinder utilisation data, route-level profitability, facility-level consumption trends, and margin structures that acquirers and lenders can underwrite. Paul's ambition is to be the platform for this consolidation, using his 18-month AskBiz operational track record as the template for professionalising acquired operations and presenting investors with a coherent growth story backed by verifiable unit economics.
Our team combines expertise in data analytics, SME strategy, and AI tools to produce practical guides that help founders and operators make better business decisions.
Ready to make smarter decisions?
AskBiz turns your business data into actionable intelligence — no spreadsheets, no consultants.
Start free — no credit card required →